Compound:
~ Export ~
|
Records:157
Gene |
Compound |
Gen_sig |
Exp_pattern |
MIR4453 |
NSC 716949 |
0.039 |
Up |
MIR4453 |
NSC 717469 |
0.008 |
Up |
MIR4453 |
Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- |
0.013 |
Down |
MIR4453 |
NSC 718131 |
0.009 |
Down |
MIR4453 |
NSC 719485 |
0.041 |
Down |
MIR4453 |
NSC 720187 |
0.001 |
Up |
MIR4453 |
Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1-(4-t-butyl)cyclohexane |
0.013 |
Down |
MIR4453 |
N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide |
0.022 |
Down |
MIR4453 |
NSC 720616 |
0.046 |
Down |
MIR4453 |
NSC 721533 |
0.007 |
Down |
MIR4453 |
3'-C-ethinylcytidine |
0.01 |
Down |
MIR4453 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.018 |
Down |
MIR4453 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.032 |
Up |
MIR4453 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.003 |
Down |
MIR4453 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.007 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:9
First Prev Next Last 
|